- Home
- CHPT vs TKNO Comparison
CHPT vs TKNO Comparison
Compare CHPT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- TKNO
- Stock Information
- Founded
- CHPT 2007
- TKNO 1996
- Country
- CHPT United States
- TKNO United States
- Employees
- CHPT N/A
- TKNO N/A
- Industry
- CHPT Industrial Specialties
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- CHPT Consumer Discretionary
- TKNO Health Care
- Exchange
- CHPT Nasdaq
- TKNO Nasdaq
- Market Cap
- CHPT 340.1M
- TKNO 256.9M
- IPO Year
- CHPT N/A
- TKNO 2021
- Fundamental
- Price
- CHPT $11.29
- TKNO $4.35
- Analyst Decision
- CHPT Hold
- TKNO
- Analyst Count
- CHPT 10
- TKNO 0
- Target Price
- CHPT $29.13
- TKNO N/A
- AVG Volume (30 Days)
- CHPT 532.9K
- TKNO 224.0K
- Earning Date
- CHPT 09-03-2025
- TKNO 08-07-2025
- Dividend Yield
- CHPT N/A
- TKNO N/A
- EPS Growth
- CHPT N/A
- TKNO N/A
- EPS
- CHPT N/A
- TKNO N/A
- Revenue
- CHPT $407,681,000.00
- TKNO $38,923,000.00
- Revenue This Year
- CHPT $2.79
- TKNO $9.52
- Revenue Next Year
- CHPT $24.20
- TKNO $15.20
- P/E Ratio
- CHPT N/A
- TKNO N/A
- Revenue Growth
- CHPT N/A
- TKNO 11.40
- 52 Week Low
- CHPT $8.55
- TKNO $4.00
- 52 Week High
- CHPT $39.20
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- CHPT 47.09
- TKNO 43.35
- Support Level
- CHPT $11.41
- TKNO $4.22
- Resistance Level
- CHPT $11.85
- TKNO $4.94
- Average True Range (ATR)
- CHPT 0.59
- TKNO 0.29
- MACD
- CHPT 0.08
- TKNO -0.00
- Stochastic Oscillator
- CHPT 39.55
- TKNO 16.75
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.